Navigation Links
Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs
Date:3/26/2012

WINSTON-SALEM, N.C., March 26, 2012 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that it has made significant advances in its two lead programs. A fourth patient was implanted in the last several weeks in the ongoing initial clinical trial of the Company's lead product candidate, the Neo-Urinary Conduit. The Company also submitted a pre-Investigational New Drug (IND) filing to the U.S. Food and Drug Administration (FDA) for its lead preclinical program, the Neo-Kidney Augment. Tengion also announced its fourth quarter and full year 2011 financial results in a separate release issued today and will hold a conference call to discuss these updates today, March 26, 2012, at 5:00 p.m. EDT.

"The implanting of the Neo-Urinary Conduit into the fourth patient and the pre-IND filing for our Neo-Kidney Augment are significant achievements for Tengion and we are confident in our ability to execute on our ambitious objectives for these two programs going forward," stated John L. Miclot, President and Chief Executive Officer of Tengion. "We have gained substantial knowledge and insight from the first three patients in the ongoing trial for the Neo-Urinary Conduit and we believe that the surgical modifications implemented for the fourth patient will improve outcomes for current and future patients in the trial. In addition, now that we have submitted a pre-IND filing to the FDA for the Neo-Kidney Augment, we are preparing a proposed clinical trial design and timeline to continue our progress toward establishing clinical proof of concept."

Neo-Urinary Conduit Clinical Program Update
Tengion has now enrolled a fourth patient in the ongoing initial clinical trial of its lead product candidate, the Neo-Urinary Conduit, which is being evaluated in bladder cancer patients requiring a urinary diversion following bladder rem
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tengion Appoints John L. Miclot President and Chief Executive Officer
2. Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference
3. Tengion Provides Business Update and Reports Third Quarter 2011 Financial Results
4. Tengion Appoints Scott Flora to Board of Directors
5. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
6. Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
7. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
8. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
9. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
10. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
11. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... --  Empire Genomics today announced that it has ... portfolio for the Japanese market.  The deal represents Empire,s international ... "We are excited to have such a proven and expert ... access to our broad genomic product and service portfolio," said ...
... MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. ... Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ... mg, 15 mg, and 20 mg. This product is the ... which is indicated for the treatment of schizophrenia and the ...
Cached Medicine Technology:Empire Genomics Chooses Funakoshi as Japan Distributor 2Mylan Launches Generic Version of Zyprexa® Tablets 2
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Most professional football players ... to the game, a new study finds. Shoulder ... their rate of return after surgery to fix the ... The new study included 60 players who had shoulder ... procedure successfully returned to play, defined as playing in ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... out regularly between outspoken celebrities or loudmouth pundits -- too ... new study suggests. High amounts of Twitter use can ... is in a long-term relationship, according to findings from an ... friction can lead to cheating and breakups, the researchers concluded, ...
(Date:7/10/2014)... a microchip-based device developed at the Massachusetts General Hospital ... Cancer Center can be cultured to establish cell lines ... July 11 issue of Science , an MGH ... a tumor,s genetic mutation over time and changing susceptibility ... cells from the blood that represent those present in ...
(Date:7/10/2014)... EAST LANSING, Mich. For those students looking to ... answer may not be spending more time in a ... New Michigan State University research shows that students who ... on MSU,s campus during their freshman and sophomore years ... The research also indicated that students with memberships stayed ...
(Date:7/10/2014)... 2014) A research review identifying the clinical indicators ... step in the process of developing evidence-based guidelines for ... report published by Neurosurgery , official ... . The journal is published by Lippincott Williams ... Kluwer Health . , Based on analysis of ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3Health News:Want a higher GPA in college? Join a gym 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
... of Pennsylvania School of Medicine and Utrecht University has deciphered ... immune response. This system, called complement, comprises a network of ... invaders. It serves as a rapid defense mechanism in most ... published in the December 24 issue of Science , ...
... Reporter , MONDAY, Dec. 27 (HealthDay News) -- Marilyn Norred has ... "They saw them back then and said, ,Someday they,ll be ... in Oklahoma City, recalled. That time came this year. Norred ... right eye on May 27 and the left eye on June ...
... FRIDAY, Dec. 24 (HealthDay News) -- For years now, doctors ... a chronic autoimmune condition that can wrack the body and ... preparing for a potential major leap forward. A ... the disease was endorsed in mid-November by an advisory panel ...
... HealthDay Reporter , FRIDAY, Dec. 24 (HealthDay News) -- ... 1999. "I would wake up very stiff and achy," said ... a while to get going in the morning." Then, after ... woke up one morning and it was like I was paralyzed," ...
... Reporter , THURSDAY, Dec. 23 (HealthDay News) -- Cynthia Duggan ... needed dental braces that she hesitated to give her veterinarian ... procedure with her husband, the couple finally decided it would ... Duggan of the 9-month-old puppy, already showing potential as a ...
... , THURSDAY, Dec. 23 (HealthDay News) -- Hospital-wide patient death ... facility,s quality of care, a new study indicates. Researchers ... They found that the measures yielded both higher- and lower-than-expected ... The findings add to an ongoing debate about the ...
Cached Medicine News:Health News:Structure of key molecule in immune system provides clues for designing drugs 2Health News:Structure of key molecule in immune system provides clues for designing drugs 3Health News:Have Cataracts? Get Surgery, Woman Urges 2Health News:Lupus Treatment May Soon Take Leap Forward 2Health News:Lupus Treatment May Soon Take Leap Forward 3Health News:For California Woman, Lupus Is Life 2Health News:Doggy Dentistry Can Now Mean Braces 2Health News:Doggy Dentistry Can Now Mean Braces 3Health News:Better Methods Needed to Measure Hospital Quality: Experts 2
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ): ... less than or equal to 35C Remelt Point (3%): ... greater than or equal to 300 gm/cm 2 ... than or equal to 0.10% DNase: Passes test RNase: ...
... sulfate (SO 4 ) ≤ 1000 mg/kg Cation traces: ... ≤ 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ ... mg/kg Mg ≤ 50 mg/kg Mn ≤ 5 mg/kg ... ≤ 5 mg/kg Zn ≤ 5 mg/kg Special grade: ...
... ≤ 500 mg/kg sulfate (SO 4 ) ≤ 1000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 10 ... K ≤ 5 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
Inquire...
Medicine Products: